Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07447206 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vascular Intervention Strategies Trial for Alzheimer's

Study acronym: VISTA
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Mar 2026 to May 2026v3
  2. Secondary endpoints: details revised at 2 of 2 entriesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The proposed pharmacist-led study is a feasibility pilot trial for the management of vascular risk factors of hypertension and hypercholesterolemia in 10 APOE ε4 carriers, 50-75, at-risk for dementia. All participants will receive angiotensin receptor blockers (ARBs) for high blood pressure, and hydrophilic statins (or a non-statin alternative) for high cholesterol over a six-month period.
Trial Details
NCT Number NCT07447206
Lead Sponsor University of Southern California
Conditions
(from sponsor)		 Hypertension, Hypercholesterolemia, Dementia Risk Factors
Related terms Hypercholesterolemia, Hypertension
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov